EXTX — Exact Therapeutics AS Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- NOK401.57m
- NOK275.46m
Annual balance sheet for Exact Therapeutics AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | NAS | NAS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 15.1 | 58.7 | 45 | 159 |
| Net Total Receivables | 4.58 | 3.86 | 5.09 | 5.99 |
| Total Other Current Assets | ||||
| Total Current Assets | 19.7 | 63.1 | 50.6 | 166 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.297 | 0.172 | 1.46 | 4.52 |
| Total Assets | 20 | 63.2 | 52.1 | 170 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 11.7 | 6.17 | 9.83 | 10.6 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 11.7 | 6.17 | 9.87 | 10.6 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 8.35 | 57.1 | 42.2 | 160 |
| Total Liabilities & Shareholders' Equity | 20 | 63.2 | 52.1 | 170 |
| Total Common Shares Outstanding |